Comment on the reports of over-estimation of ASCVD risk using the 2013 AHA/ACC risk equation

Circulation. 2014 Jan 14;129(2):266-7. doi: 10.1161/CIRCULATIONAHA.113.007648. Epub 2013 Dec 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiovascular Diseases / prevention & control*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Practice Guidelines as Topic*
  • Primary Prevention*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors